Litcius/Paper detail

Ginsenoside Rk1 Ameliorates Non-Alcoholic Fatty Liver Disease by Targeting CD36 to Modulate the AMPK Signaling Pathway

Yuqing Wu, Zhiguang Duan, Linlin Qu, Yan‐Nan Liu, Xiaoxuan Ma, Daidi Fan

2025Food Research International11 citationsDOI

Topics & Concepts

AMPKCD36Fatty liverSignal transductionPharmacologyChemistryAMP-activated protein kinaseAlcoholic liver diseaseDiseaseCell biologyMedicineBiochemistryBiologyInternal medicineProtein kinase AKinaseReceptorCirrhosisLiver Disease Diagnosis and TreatmentGinseng Biological Effects and ApplicationsDiet, Metabolism, and Disease
Ginsenoside Rk1 Ameliorates Non-Alcoholic Fatty Liver Disease by Targeting CD36 to Modulate the AMPK Signaling Pathway | Litcius